Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy O Mathew

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 16, 2019
Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategiesJanani Rangaswami, Roy O Mathew, Raviprasenna Parasuraman, et al.
The American Journal of Medicine|November 4, 2023
Body Mass Index and Clinical and Health Status Outcomes in Chronic Coronary Disease and Advanced Kidney Disease in the ISCHEMIA-CKD TrialRoy O Mathew, Evgeny I Kretov, Zhen Huang, et al.
JAMA Cardiology|June 29, 2022
Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney FunctionSripal Bangalore, Judith S Hochman, Susanna R Stevens, et al.
Journal of the American College of Cardiology|May 14, 2021
Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD TrialCharles A Herzog, Mengistu A Simegn, Yifan Xu, et al.
Cardiovascular Drugs and Therapy|November 29, 2022
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y<sub>12</sub> Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI StudyRoy O Mathew, Mandeep S Sidhu, Charanjit S Rihal, et al.
Circulation. Cardiovascular Quality and Outcomes|October 4, 2022
Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD TrialRoy O Mathew, David J Maron, Rebecca Anthopolos, et al.
Journal of the American Heart Association|March 9, 2022
Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKDCarlo Briguori, Roy O Mathew, Zhen Huang, et al.
JACC. Cardiovascular Interventions|January 25, 2023
Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD TrialMandeep S Sidhu, Karen P Alexander, Zhen Huang, et al.
The New England Journal of Medicine|April 1, 2020
Management of Coronary Disease in Patients with Advanced Kidney DiseaseSripal Bangalore, David J Maron, Sean M O'Brien, et al.
Circulation|October 9, 2023
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart AssociationChiadi E Ndumele, Janani Rangaswami, Sheryl L Chow, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 16, 2019
Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategiesJanani Rangaswami, Roy O Mathew, Raviprasenna Parasuraman, et al.
The American Journal of Medicine|November 4, 2023
Body Mass Index and Clinical and Health Status Outcomes in Chronic Coronary Disease and Advanced Kidney Disease in the ISCHEMIA-CKD TrialRoy O Mathew, Evgeny I Kretov, Zhen Huang, et al.
JAMA Cardiology|June 29, 2022
Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney FunctionSripal Bangalore, Judith S Hochman, Susanna R Stevens, et al.
Journal of the American College of Cardiology|May 14, 2021
Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD TrialCharles A Herzog, Mengistu A Simegn, Yifan Xu, et al.
Cardiovascular Drugs and Therapy|November 29, 2022
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y<sub>12</sub> Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI StudyRoy O Mathew, Mandeep S Sidhu, Charanjit S Rihal, et al.
Circulation. Cardiovascular Quality and Outcomes|October 4, 2022
Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD TrialRoy O Mathew, David J Maron, Rebecca Anthopolos, et al.
Journal of the American Heart Association|March 9, 2022
Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKDCarlo Briguori, Roy O Mathew, Zhen Huang, et al.
JACC. Cardiovascular Interventions|January 25, 2023
Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD TrialMandeep S Sidhu, Karen P Alexander, Zhen Huang, et al.
The New England Journal of Medicine|April 1, 2020
Management of Coronary Disease in Patients with Advanced Kidney DiseaseSripal Bangalore, David J Maron, Sean M O'Brien, et al.
Circulation|October 9, 2023
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart AssociationChiadi E Ndumele, Janani Rangaswami, Sheryl L Chow, et al.
Pageof 11